Erratum to: Multiple sclerosis (Nature Reviews Disease Primers, (2018), 4, 1, (43), 10.1038/s41572-018-0041-4)

Massimo Filippi, Amit Bar-Or, Fredrik Piehl, Paolo Preziosa, Alessandra Solari, Sandra Vukusic, Maria A. Rocca

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the originally published version of this article, in Table 4, Ocrelizumab was incorrectly referred to as an anti-CD25 antibody. This has been corrected in the HTML and PDF versions of the article to an anti-CD20 antibody.

Original languageEnglish
Article number49
JournalNature Reviews Disease Primers
Volume4
Issue number1
DOIs
Publication statusPublished - Dec 1 2018

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Erratum to: Multiple sclerosis (Nature Reviews Disease Primers, (2018), 4, 1, (43), 10.1038/s41572-018-0041-4)'. Together they form a unique fingerprint.

Cite this